Bioelectrical impedance outperforms waist circumference for predicting cardiometabolic risk in Congolese hypertensive subjects: a cross-sectional study

BMC Cardiovascular Disorders

Michel P Hermans²  Jean-René M’Buyamba-Kabangu³  Achile Mwira Bapolisi¹  Philippe Bianga Katchunga¹ 

[1] Cardiology Unit, Department of Internal Medicine, Provincial General Hospital of Bukavu, Catholic University of Bukavu, Bukavu, The Democratic Republic of Congo;Department of Endocrinology, Saint Luc Academic Hospital, Brussels, Belgium;Hypertension Unit, Department of Internal Medicine, University of Kinshasa Hospital, Kinshasa, The Democratic Republic of Congo

关键词: Congolese;    Hypertensive;    Waist circumference;    Bioelectrical impedance;   

Others  :  1136414
DOI  :  10.1186/s12872-015-0011-7

 received in 2014-12-10, accepted in 2015-02-19,  发布年份 2015

【 摘 要 】

Background

Waist circumference threshold values used in sub-Saharan Africa correspond to those of European populations and are therefore inappropriate. Thus, they may over predict insulin resistance, especially in hypertensive Africans, in whom there is often no association between blood pressure and insulin resistance. Using bioelectrical impedance measurement in sub-Saharan Africa could possibly be advantageous to overcome the shortcomings of waist circumference measurement. The aim of this study was to evaluate the contribution of body composition estimation by bioelectrical impedance to predict cardiometabolic risk in Congolese hypertensive subjects.

Methods

Cardiovascular profiling and body composition analysis by bioelectrical impedance was measured in 400 patients (men = 40%; age = 51.1 ± 12.6 years). Patients were diagnosed with a metabolic syndrome (MS) according to the IDF Criteria with and without the “blood pressure” criterion to remove any confounding autocorrelation bias, a visceral fat-MS (with and without the “blood pressure” criterion) being defined by the presence of ≥ 2 criteria with the precondition of excess visceral fat defined by a bio impedance measurement score >10/30. Total cardiovascular risk was assessed using the criteria of Framingham-2008.

Results

The frequencies of enlarged waist circumference (71.9% vs 68.9%, p = 0.52) and IDF-MS without blood pressure criterion (24.9% vs 21.9%, p = 0.48) were similar among hypertensive vs. non hypertensive however excess visceral fat (57.6% vs 33.8%, p <0.0001) as well as visceral fat-MS without blood pressure criterion (18.9% vs 11.3%, p = 0.04) were more prevalent among hypertensive. Finally, total cardiovascular risk as well as arterial hypertension risk were associated with visceral fat, but not with waist circumference (p > 0.05).

Conclusions

Pending the determination of thresholds values for pathological waist circumference adapted to sub-Saharan populations, using bioelectrical impedance measurement may contribute to better characterize the cardiometabolic risk and the insulin resistant phenotype of hypertensive sub-Saharan Africans.

【 授权许可】

   
2015 Katchunga et al.; licensee BioMed Central.

【 参考文献 】

• [1]Kearney PM, Whelton M, Reynolds K: Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-23.
• [2]Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, et al.: Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004, 43:1239-45.
• [3]Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al.: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 2011, 377(9765):557-67.
• [4]Eckel RH, Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2005, 365(9468):1415-28.
• [5]Cao H: Adipocytokines in obesity and metabolic disease. J Endocrinol 2014, 220:T47-59.
• [6]World Health Organization: Definition, diagnosis and classification of Diabetes mellitus and its complications. WHO, Geneva, Switzerland; 1999.
• [7]Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al.: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-9.
• [8]Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al.: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-16.
• [9]Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al.: ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013, 31(7):1281-357.
• [10]Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al.: Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the I.D.F Task Force on Epidemiology and Prevention; N.H.L and Blood Institute; A.H.A; W.H.F; I.A.S; and I.A. for the Study of Obesity. Circulation 2009, 120:1640-5.
• [11]World Health Organization: A global brief of hypertension. Silent killer. Global public health crisis. WHO, Geneva, Switzerland; 2013.
• [12]Saad FM, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, et al.: Racial differences in the relation between blood pressure and insulin resistance. New Engl J Med 1991, 234(11):733-9.
• [13]Motala AA, Esterhuizen T, Pirie FJ, Omar MA: The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South african community. Diabetes Care 2011, 34(4):1032-7.
• [14]Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya JC: Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis 2007, 193(1):70-6.
• [15]Sumner AE, Sen S, Ricks M, Frempong BA, Sebring NG, Kushner H: Determining the waist circumference in African Americans which best predicts insulin resistance. Obesity 2008, 16:841-6.
• [16]Katchunga BP, Hermans MP, Bamuleke AB, Katoto CP, Kabinda MJ: Relationship between waist circumference, visceral fat and metabolic syndrome in a Congolese community: Further investigations are still very necessary. PAMJ 2013, 14(20):8p.
• [17]Baguma M, Ilimbizi B, Katchunga P: Parity and metabolic syndrome risk in the Congolese women in South Kivu, Democratic Republic of Congo. Obésité 2014, 9:293-8.
• [18]Zhou JY, Ge H, Zhu MF, Wang LJ, Chen L, Tan YZ, et al.: Neck circumference as an independent predictive contributor to cardio-metabolic syndrome. Cardiovasc Diabetol 2013, 12:76. BioMed Central Full Text
• [19]Bosy-Westphal A, Later W, Hitze B, Sato T, Kossel E, Gluer CC, et al.: Accuracy of bioelectrical impedance consumer devices for measurement of body composition in comparison to whole body magnetic resonance imaging and dual X-ray absorptiometry. Obes Facts 2008, 1(6):319-24.
• [20]American Diabetes Association: Diagnosis and Classification of Diabetes Mellitus Diabetes Care 2014, 37(Suppl 1):S81-90.
• [21]Alberti KG, Zimmet P, Shaw J: IDF Epidemiology Task Force Consensus Group: The metabolic syndrome: a new worldwide definition. Lancet 2005, 366:1059-62.
• [22]Agostino RBD, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al.: General cardiovascular risk profile for use in primary care: The Framingham Heart study. Circulation 2008, 117:743-53.
• [23]Aydin M, Dumlu T, Alemdar R, Kayapinar O, Celbek G, Kababacak A, et al.: Correlation between the body fat composition and high sensitive C-reactive protein in Turkish adults. Endocr Regul 2012, 46(3):147-52.
• [24]Bioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference Statement 1994 Dec. Am J Clin Nutr. 1996;64 (3 Suppl):524S–32S.
• [25]Akande TO, Adeleye JO, Kadiri S: Insulin resistance in Nigerians with essential hypertension. Afr Health Sci 2013, 13(3):655-60.
• [26]Katchunga P, Hermans MP, Manwa B, Lepira F, Kashongwe Z, M’Buyamba-Kabangu JR: Hypertension, insulin resistance and chronic kidney disease in type 2 diabetes patients from South Kivu, DR Congo. Nephrol Ther 2010, 6(6):520-5.
• [27]Zoratti R: A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin? Eur J Epidemiol 1998, 14(1):9-21.
• [28]Sakurai T, Iimuro S, Araki A, Umegaki H, Ohashi Y, Yokono K, et al.: Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus. Gerontology 2010, 56(2):141-9.
• [29]Kim HI, Kim JT, Yu SH, Kwak SH, Jang HC, Park KS, et al.: Gender differences in diagnostic values of visceral fat area and waist circumference for predicting metabolic syndrome in Koreans. J Korean Med Sci 2011, 26(7):906-13.